San Francisco, June 16, 2025 – http://www.ctrl-tx.com is thrilled to announce a strategic partnership with Moffitt Cancer Center, aimed at pioneering the next generation of cellular immunotherapies for tumor treatment. This collaboration will primarily focus on advancing preclinical and clinical studies of circulating tumor-reactive lymphocyte-based therapies for solid tumors, with the potential for expansion into additional therapeutic indications.

Both organizations share a commitment to innovation in cancer treatment, and we are eager to leverage our combined expertise to develop therapies that can significantly improve the lives of patients and their families. 

We look forward to working closely with Moffitt Cancer Center to bring forth groundbreaking therapies that not only provide hope but also drive meaningful change in the fight against cancer.

Contacts:

Contact@ctrl-tx.com